Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs Paclitaxel Schedules in Metastatic Breast Cancer
NCT00006120Phase 2Unknown
- Sponsor
- GERCOR
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of docetaxel and paclitaxel in breast cancer (4 arms), sponsored by GERCOR. Primary endpoints: Response Rate, Progression Free Survival and 1 more. Status: unknown.
02
Drugs
docetaxelpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006120.